These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7847054)

  • 1. Rising mortality from motor neurone disease in Sweden 1961-1990: the relative role of increased population life expectancy and environmental factors.
    Neilson S; Gunnarsson LG; Robinson I
    Acta Neurol Scand; 1994 Sep; 90(3):150-9. PubMed ID: 7847054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rising mortality from motor neurone disease: an explanation.
    Neilson S; Robinson I; Clifford Rose F; Hunter M
    Acta Neurol Scand; 1993 Mar; 87(3):184-91. PubMed ID: 8475687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new analysis of mortality from motor neurone disease in Japan, 1950-1990: rise and fall in the postwar years.
    Neilson S; Robinson I; Kondo K
    J Neurol Sci; 1993 Jul; 117(1-2):46-53. PubMed ID: 8410066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009.
    Mehal JM; Holman RC; Schonberger LB; Sejvar JJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):346-52. PubMed ID: 23621426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.
    Chancellor AM; Warlow CP
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1106-15. PubMed ID: 1479386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland.
    Elian M; Dean G
    Neuroepidemiology; 1992; 11(4-6):236-43. PubMed ID: 1291887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease.
    Forbes RB; Colville S; Cran GW; Swingler RJ;
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1753-5. PubMed ID: 15548498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor neuron disease mortality and lifetime petrol lead exposure: Evidence from national age-specific and state-level age-standardized death rates in Australia.
    Zahran S; Laidlaw MA; Rowe DB; Ball AS; Mielke HW
    Environ Res; 2017 Feb; 153():181-190. PubMed ID: 27992849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor neuron disease mortality rates in New Zealand 1992-2013.
    Cao MC; Chancellor A; Charleston A; Dragunow M; Scotter EL
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):285-293. PubMed ID: 29382218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation.
    Neilson S; Robinson I; Alperovitch A
    J Neurol; 1994 Jun; 241(7):448-55. PubMed ID: 7931447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential gains in life expectancy by reducing inequality of lifespans in Denmark: an international comparison and cause-of-death analysis.
    Aburto JM; Wensink M; van Raalte A; Lindahl-Jacobsen R
    BMC Public Health; 2018 Jul; 18(1):831. PubMed ID: 29973183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of amyotrophic lateral sclerosis.
    Kurtzke JF
    Adv Neurol; 1982; 36():281-302. PubMed ID: 6983824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leaving Sweden behind: Gains in life expectancy in Canada.
    Auger N; Le Serbon E; Rostila M
    Scand J Public Health; 2015 Jun; 43(4):340-7. PubMed ID: 25834068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival.
    Skillbäck T; Mattsson N; Blennow K; Zetterberg H
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):397-403. PubMed ID: 28631955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline and rise of mortality from motor neuron disease in Spain, 1960-1989: demographic, environmental and competitive influences.
    Neilson S; Robinson I; de Pedro-Cuesta J; Veiga-Cabo J
    Neuroepidemiology; 1996; 15(4):180-91. PubMed ID: 8817500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966-1989: evidence for a susceptible subpopulation.
    Neilson S; Robinson I; Nymoen EH
    J Neurol Sci; 1994 Apr; 122(2):148-54. PubMed ID: 8021698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential features of motor neuron disease mortality in Spain.
    Veiga-Cabo J; Almazán-Isla J; Sendra-Gutiérrez JM; de Pedro-Cuesta J
    Int J Epidemiol; 1997 Oct; 26(5):1024-32. PubMed ID: 9363524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in motor neuron disease: association with latitude and air lead levels in Spain.
    Santurtún A; Villar A; Delgado-Alvarado M; Riancho J
    Neurol Sci; 2016 Aug; 37(8):1271-5. PubMed ID: 27098242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register.
    Kurian KM; Forbes RB; Colville S; Swingler RJ
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):84-7. PubMed ID: 19091712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing mortality patterns that led life expectancy in Japan to surpass Sweden's: 1972-1982.
    Yanagishita M; Guralnik JM
    Demography; 1988 Nov; 25(4):611-24. PubMed ID: 3267542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.